Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aphasia, Primary Progressive | 71 | 2024 | 87 | 20.290 |
Why?
|
| Alzheimer Disease | 50 | 2024 | 497 | 9.510 |
Why?
|
| Memory, Episodic | 9 | 2023 | 55 | 4.320 |
Why?
|
| Frontotemporal Dementia | 17 | 2024 | 29 | 3.990 |
Why?
|
| Atrophy | 32 | 2024 | 119 | 3.830 |
Why?
|
| Cognition | 14 | 2024 | 580 | 3.620 |
Why?
|
| Aging | 14 | 2024 | 716 | 3.210 |
Why?
|
| Neuropsychological Tests | 38 | 2024 | 505 | 3.180 |
Why?
|
| Brain | 26 | 2024 | 2281 | 3.030 |
Why?
|
| Frontotemporal Lobar Degeneration | 15 | 2024 | 15 | 2.880 |
Why?
|
| Language | 11 | 2024 | 154 | 2.840 |
Why?
|
| Aphasia | 5 | 2024 | 15 | 2.540 |
Why?
|
| Temporal Lobe | 16 | 2023 | 176 | 2.490 |
Why?
|
| Dementia | 9 | 2024 | 193 | 2.350 |
Why?
|
| Cerebral Cortex | 15 | 2020 | 589 | 2.330 |
Why?
|
| Language Tests | 15 | 2022 | 37 | 2.280 |
Why?
|
| Comprehension | 9 | 2022 | 80 | 2.150 |
Why?
|
| Neurodegenerative Diseases | 4 | 2023 | 51 | 2.070 |
Why?
|
| Cognitive Dysfunction | 10 | 2024 | 145 | 1.760 |
Why?
|
| Aged | 72 | 2024 | 19077 | 1.580 |
Why?
|
| tau Proteins | 12 | 2023 | 74 | 1.520 |
Why?
|
| Semantics | 11 | 2022 | 48 | 1.510 |
Why?
|
| Humans | 127 | 2024 | 89063 | 1.390 |
Why?
|
| Speech | 7 | 2022 | 85 | 1.270 |
Why?
|
| Aged, 80 and over | 35 | 2024 | 6777 | 1.220 |
Why?
|
| Quality of Life | 6 | 2023 | 1662 | 1.210 |
Why?
|
| Neurofibrillary Tangles | 10 | 2022 | 46 | 1.190 |
Why?
|
| Speech-Language Pathology | 2 | 2018 | 4 | 1.190 |
Why?
|
| Supranuclear Palsy, Progressive | 3 | 2023 | 21 | 1.180 |
Why?
|
| Amnesia | 3 | 2021 | 15 | 1.100 |
Why?
|
| Longitudinal Studies | 18 | 2024 | 1067 | 1.080 |
Why?
|
| Pick Disease of the Brain | 2 | 2024 | 6 | 1.070 |
Why?
|
| Middle Aged | 66 | 2024 | 25863 | 1.050 |
Why?
|
| Vocabulary | 5 | 2024 | 15 | 1.030 |
Why?
|
| Entorhinal Cortex | 3 | 2022 | 15 | 1.000 |
Why?
|
| Male | 72 | 2024 | 42251 | 0.980 |
Why?
|
| Magnetic Resonance Imaging | 30 | 2023 | 3443 | 0.980 |
Why?
|
| Apolipoprotein E4 | 6 | 2023 | 27 | 0.960 |
Why?
|
| Female | 73 | 2024 | 46011 | 0.960 |
Why?
|
| Wernicke Encephalopathy | 1 | 2023 | 6 | 0.890 |
Why?
|
| Wernicke Area | 3 | 2020 | 3 | 0.870 |
Why?
|
| Language Development Disorders | 1 | 2022 | 24 | 0.850 |
Why?
|
| Memory Disorders | 4 | 2023 | 68 | 0.850 |
Why?
|
| DNA-Binding Proteins | 11 | 2023 | 1241 | 0.850 |
Why?
|
| Amyloid beta-Peptides | 12 | 2024 | 212 | 0.840 |
Why?
|
| Communication Disorders | 1 | 2022 | 7 | 0.840 |
Why?
|
| Aphasia, Broca | 4 | 2020 | 5 | 0.820 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 207 | 0.790 |
Why?
|
| Positron-Emission Tomography | 8 | 2023 | 336 | 0.790 |
Why?
|
| Communication | 6 | 2022 | 457 | 0.790 |
Why?
|
| Language Therapy | 5 | 2023 | 5 | 0.770 |
Why?
|
| Tauopathies | 4 | 2024 | 14 | 0.750 |
Why?
|
| Apolipoproteins E | 7 | 2023 | 130 | 0.740 |
Why?
|
| Frontal Lobe | 5 | 2016 | 131 | 0.710 |
Why?
|
| Anomia | 4 | 2020 | 6 | 0.690 |
Why?
|
| Verbal Learning | 2 | 2017 | 29 | 0.690 |
Why?
|
| Behavioral Symptoms | 2 | 2016 | 15 | 0.640 |
Why?
|
| Biomarkers | 12 | 2024 | 1755 | 0.630 |
Why?
|
| Healthy Aging | 1 | 2018 | 10 | 0.610 |
Why?
|
| Functional Laterality | 3 | 2018 | 200 | 0.590 |
Why?
|
| Autopsy | 7 | 2022 | 122 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2020 | 2335 | 0.580 |
Why?
|
| Self-Help Groups | 1 | 2017 | 14 | 0.580 |
Why?
|
| Hippocampus | 1 | 2021 | 447 | 0.580 |
Why?
|
| Plaque, Amyloid | 4 | 2022 | 59 | 0.540 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 166 | 0.530 |
Why?
|
| Nerve Net | 3 | 2020 | 372 | 0.530 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 207 | 0.530 |
Why?
|
| Acoustic Stimulation | 3 | 2017 | 131 | 0.530 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2015 | 17 | 0.510 |
Why?
|
| Psychological Techniques | 1 | 2015 | 3 | 0.510 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2020 | 1239 | 0.490 |
Why?
|
| Disease Progression | 6 | 2021 | 1488 | 0.480 |
Why?
|
| C9orf72 Protein | 7 | 2023 | 18 | 0.440 |
Why?
|
| Caregivers | 3 | 2024 | 159 | 0.420 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2024 | 125 | 0.410 |
Why?
|
| Cognitive Aging | 2 | 2022 | 8 | 0.410 |
Why?
|
| Apraxias | 2 | 2023 | 3 | 0.410 |
Why?
|
| Age of Onset | 4 | 2019 | 312 | 0.410 |
Why?
|
| Executive Function | 3 | 2021 | 91 | 0.390 |
Why?
|
| Gyrus Cinguli | 3 | 2017 | 46 | 0.380 |
Why?
|
| Memory, Short-Term | 1 | 2014 | 225 | 0.380 |
Why?
|
| Age Factors | 6 | 2021 | 1867 | 0.370 |
Why?
|
| Microglia | 3 | 2020 | 107 | 0.360 |
Why?
|
| Amyloid | 4 | 2023 | 94 | 0.360 |
Why?
|
| Eye Movements | 3 | 2022 | 119 | 0.360 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2020 | 4 | 0.360 |
Why?
|
| Auditory Cortex | 1 | 2011 | 59 | 0.360 |
Why?
|
| Brain Mapping | 5 | 2015 | 564 | 0.350 |
Why?
|
| Neural Pathways | 5 | 2020 | 319 | 0.340 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 1837 | 0.320 |
Why?
|
| Photic Stimulation | 6 | 2019 | 501 | 0.320 |
Why?
|
| Neurons | 7 | 2022 | 1580 | 0.310 |
Why?
|
| Memory | 3 | 2021 | 220 | 0.310 |
Why?
|
| Case-Control Studies | 8 | 2020 | 1855 | 0.300 |
Why?
|
| Dyslexia | 2 | 2023 | 11 | 0.300 |
Why?
|
| White Matter | 3 | 2023 | 84 | 0.280 |
Why?
|
| Learning | 2 | 2023 | 285 | 0.260 |
Why?
|
| Aniline Compounds | 3 | 2021 | 58 | 0.250 |
Why?
|
| Language Disorders | 2 | 2017 | 9 | 0.240 |
Why?
|
| Reaction Time | 4 | 2017 | 310 | 0.230 |
Why?
|
| Speech Therapy | 2 | 2023 | 9 | 0.230 |
Why?
|
| Amyloidogenic Proteins | 4 | 2023 | 14 | 0.230 |
Why?
|
| Gliosis | 2 | 2022 | 35 | 0.220 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 6 | 0.220 |
Why?
|
| United States | 6 | 2024 | 6955 | 0.220 |
Why?
|
| Behavior Therapy | 1 | 2023 | 84 | 0.220 |
Why?
|
| Carbolines | 1 | 2022 | 8 | 0.210 |
Why?
|
| Ethylene Glycols | 2 | 2020 | 10 | 0.210 |
Why?
|
| Broca Area | 2 | 2020 | 2 | 0.210 |
Why?
|
| Goals | 1 | 2023 | 67 | 0.210 |
Why?
|
| Social Support | 2 | 2015 | 208 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2752 | 0.200 |
Why?
|
| Single-Blind Method | 1 | 2022 | 150 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 46 | 0.200 |
Why?
|
| Radiopharmaceuticals | 2 | 2020 | 193 | 0.190 |
Why?
|
| Linguistics | 2 | 2024 | 12 | 0.190 |
Why?
|
| Early Diagnosis | 1 | 2021 | 125 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2020 | 71 | 0.180 |
Why?
|
| Prevalence | 3 | 2018 | 1240 | 0.180 |
Why?
|
| Mutation | 6 | 2023 | 4132 | 0.180 |
Why?
|
| Prospective Studies | 4 | 2023 | 4273 | 0.180 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 5 | 0.180 |
Why?
|
| Rest | 1 | 2020 | 49 | 0.170 |
Why?
|
| Genetic Testing | 2 | 2023 | 537 | 0.170 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 24 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 52 | 0.160 |
Why?
|
| Parietal Lobe | 1 | 2020 | 119 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2024 | 551 | 0.160 |
Why?
|
| Adult | 9 | 2019 | 26507 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 1670 | 0.160 |
Why?
|
| Acetylcholinesterase | 1 | 2018 | 47 | 0.160 |
Why?
|
| Knowledge | 1 | 2018 | 29 | 0.160 |
Why?
|
| Neurology | 1 | 2019 | 74 | 0.150 |
Why?
|
| Verbal Behavior | 2 | 2008 | 32 | 0.150 |
Why?
|
| Retrospective Studies | 6 | 2021 | 9003 | 0.150 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 81 | 0.150 |
Why?
|
| Cognition Disorders | 2 | 2017 | 235 | 0.150 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2017 | 4 | 0.150 |
Why?
|
| Disease Management | 1 | 2019 | 329 | 0.140 |
Why?
|
| Occipital Lobe | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2024 | 2863 | 0.140 |
Why?
|
| Limbic System | 1 | 2016 | 23 | 0.140 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 496 | 0.140 |
Why?
|
| Dominance, Cerebral | 1 | 2016 | 66 | 0.130 |
Why?
|
| Family | 2 | 2019 | 325 | 0.130 |
Why?
|
| Aphasia, Wernicke | 1 | 2015 | 1 | 0.130 |
Why?
|
| Narration | 1 | 2015 | 17 | 0.130 |
Why?
|
| Phonetics | 2 | 2012 | 36 | 0.130 |
Why?
|
| Organ Size | 4 | 2020 | 369 | 0.130 |
Why?
|
| Molecular Imaging | 1 | 2016 | 65 | 0.120 |
Why?
|
| Autophagy | 1 | 2017 | 159 | 0.120 |
Why?
|
| Forecasting | 1 | 2016 | 305 | 0.120 |
Why?
|
| Emotional Intelligence | 1 | 2015 | 22 | 0.120 |
Why?
|
| Zebrafish | 1 | 2017 | 319 | 0.120 |
Why?
|
| Genotype | 3 | 2018 | 1848 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 359 | 0.110 |
Why?
|
| Alleles | 2 | 2017 | 1135 | 0.110 |
Why?
|
| Community Mental Health Services | 1 | 2013 | 17 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2013 | 47 | 0.110 |
Why?
|
| Odorants | 1 | 2013 | 70 | 0.110 |
Why?
|
| Agraphia | 1 | 2012 | 1 | 0.100 |
Why?
|
| Word Association Tests | 1 | 2012 | 5 | 0.100 |
Why?
|
| Phenotype | 4 | 2023 | 2439 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 164 | 0.100 |
Why?
|
| Data Collection | 2 | 2023 | 375 | 0.100 |
Why?
|
| Pattern Recognition, Visual | 2 | 2012 | 154 | 0.100 |
Why?
|
| Comorbidity | 1 | 2014 | 948 | 0.090 |
Why?
|
| Reading | 2 | 2009 | 31 | 0.090 |
Why?
|
| Inclusion Bodies | 2 | 2020 | 34 | 0.090 |
Why?
|
| Speech Disorders | 1 | 2009 | 19 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2018 | 901 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2612 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2011 | 685 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 887 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 685 | 0.080 |
Why?
|
| Northwestern United States | 1 | 2008 | 7 | 0.080 |
Why?
|
| Social Behavior Disorders | 1 | 2008 | 19 | 0.080 |
Why?
|
| Medical Records | 1 | 2008 | 120 | 0.070 |
Why?
|
| Psycholinguistics | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1706 | 0.070 |
Why?
|
| Signal Detection, Psychological | 1 | 2006 | 20 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1591 | 0.070 |
Why?
|
| Nerve Degeneration | 2 | 2020 | 83 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 6288 | 0.060 |
Why?
|
| Polypharmacy | 1 | 2024 | 15 | 0.060 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2024 | 3 | 0.060 |
Why?
|
| Self-Management | 1 | 2024 | 39 | 0.060 |
Why?
|
| Presenilin-2 | 1 | 2023 | 25 | 0.060 |
Why?
|
| Neurogranin | 1 | 2023 | 3 | 0.060 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2023 | 9 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 1063 | 0.060 |
Why?
|
| Electrons | 1 | 2023 | 50 | 0.060 |
Why?
|
| Angiotensins | 1 | 2023 | 5 | 0.060 |
Why?
|
| Presenilin-1 | 1 | 2023 | 100 | 0.060 |
Why?
|
| Demography | 1 | 2024 | 181 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 1592 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2024 | 334 | 0.050 |
Why?
|
| Visual Perception | 1 | 2006 | 326 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2023 | 144 | 0.050 |
Why?
|
| Dentate Gyrus | 1 | 2023 | 32 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 182 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2024 | 291 | 0.050 |
Why?
|
| RNA Interference | 1 | 2024 | 376 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2024 | 138 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2023 | 117 | 0.050 |
Why?
|
| Health Status | 1 | 2024 | 370 | 0.050 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2021 | 1 | 0.050 |
Why?
|
| Stilbenes | 1 | 2021 | 25 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 65 | 0.050 |
Why?
|
| Emotions | 1 | 2024 | 349 | 0.050 |
Why?
|
| Patient Selection | 1 | 2024 | 682 | 0.050 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2020 | 8 | 0.040 |
Why?
|
| Gray Matter | 1 | 2020 | 35 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 11737 | 0.040 |
Why?
|
| Life Style | 1 | 2019 | 172 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 180 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 374 | 0.040 |
Why?
|
| Longevity | 1 | 2018 | 57 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2019 | 310 | 0.040 |
Why?
|
| Animals | 3 | 2024 | 27317 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 25 | 0.040 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Cell Count | 1 | 2017 | 200 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 373 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 638 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 106 | 0.040 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2016 | 13 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 196 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1212 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 149 | 0.030 |
Why?
|
| Attention | 1 | 2020 | 394 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 329 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 293 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cell Size | 1 | 2015 | 68 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 463 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 491 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1528 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 432 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2017 | 378 | 0.030 |
Why?
|
| Cues | 1 | 2015 | 177 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 302 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 850 | 0.030 |
Why?
|
| Olfactory Perception | 1 | 2013 | 21 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 578 | 0.030 |
Why?
|
| Heart | 1 | 2016 | 573 | 0.030 |
Why?
|
| Articulation Disorders | 1 | 2012 | 1 | 0.030 |
Why?
|
| Form Perception | 1 | 2012 | 37 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 306 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3717 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 433 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2362 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2399 | 0.020 |
Why?
|
| Child | 1 | 2018 | 7149 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2657 | 0.010 |
Why?
|